Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06496412

Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM

Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM: a Randomized Controlled, Triple-blind Clinical Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Second Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective, single-center, parallel-design,1:1 randomized controlled trial with triple blinding. It aims to investigate the effects of fecal microbiota transplantation (FMT) on cognitive function in patients with long-term type 1 diabetes (T1D), as well as its effects on other complications, glycemic control, insulin dosage, insulin resistance, peripheral blood immune cells, serum metabolites, and safety. This study is divided into two phases for recruiting participants. The first phase recruits 10 individuals (experimental group: 5, control group: 5), while the second phase recruits 30 individuals (experimental group: 15, control group: 15).The main research objectives are as follows: 1. To observe the difference in cognitive function between the FMT group and the placebo group, with the indicators including cognitive scale scores, changes in brain MRI imaging indicators and brain age at week 24 compared to baseline. 2. To observe the difference in other complications between the FMT group and the placebo group, with the indicators including changes in urinary albumin/creatinine ratio, fundus photography, carotid intima-media thickness, and arterial pulse wave velocity at week 24 compared to baseline. 3. To observe the difference in glycemic control, insulin dosage, insulin resistance, peripheral blood immune cells, gut microbiota, and serum metabolites between the FMT group and the placebo group. 4. To evaluate the safety of FMT.

Conditions

Interventions

TypeNameDescription
DRUGfecal microbiota transplantationTake fecal microbiota capsules.
DRUGPlaceboTake placebo capsules.

Timeline

Start date
2024-04-20
Primary completion
2026-12-30
Completion
2027-12-30
First posted
2024-07-11
Last updated
2024-07-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06496412. Inclusion in this directory is not an endorsement.